Thymic alterations induced by plasmodium berghei: Expression of matrix metalloproteinases and their tissue inhibitors

Cellular Immunology

Volumn 279, Issue 1, 2012, Pages 53-59

  Lima, Alliny Carolina Dionete ^a   Francelin, Carolina ^a   Ferrucci, Danilo Lopes ^a   Stach Machado, Dagmar Ruth ^a   Verinaud, Liana ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Malaria; Metalloproteinases; Plasmodium berghei; Thymic atrophy; Thymus

Indexed keywords

GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; ERYTHROCYTE; EXTRACELLULAR MATRIX; MALE; MORTALITY; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYMUS; THYMUS ATROPHY; THYMUS FUNCTION;

ANIMALS; GENE EXPRESSION PROFILING; HOST-PARASITE INTERACTIONS; IMMUNOHISTOCHEMISTRY; MALARIA; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; PARASITEMIA; PLASMODIUM BERGHEI; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYMUS GLAND; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

ANIMALIA; MUS; PLASMODIUM BERGHEI;

EID: 84871660766     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.09.006     Document Type: Article

References (37)

1. Savino W., Dalmau S.R., De Almeida V.C. Role of extracellular matrix-mediated interactions in thymocyte migration. Dev. Immunol. 2000, 7:279-291.
2. Boyd R.L., Tucek C.L., Godfrey D.I., et al. The thymic microenvironment. Immunol. Today 1993, 14:445-459.
3. Manley N.R., Richie E.R., Blackburn C.C., et al. Structure and function of the thymic microenvironment. Front Biosci. 2011, 17:461-477.
4. Petrie H.T., Zúñiga-Pflücker J.C. Zoned out: functional mapping of stromal signaling microenvironments in the thymus. Annu. Rev. Immunol. 2007, 25:649-679.
5. W. Savino, The thymus is a common target organ in infectious diseases, PLoS Pathog. 6: e62 (2006) 472-483.
6. Brito V.N., Souto P.C., Cruz-Hofling M.A., Ricci L.C., Verinaud L. Thymic invasion and atrophy induced by Paracoccidioides brasiliensis in BALB/c mice. Med. Mycol. 2002, 41:1-5.
7. Nagib P.R., Gameiro J., Stivanin-Silva L.G., et al. Thymic microenvironmental alterations in experimentally-induced diabetes. Immunobiology 2010, 215:971-979.
8. Andrade C.F., Gameiro J., Nagib P.R.A., et al. Thymic alterations in Plasmodium berghei-infected mice. Cell. Immunol. 2008, 253:1-4.
9. Gameiro J., Nagib P.R., Andrade C.F. Changes in cell migration-related molecules expressed by thymic microenvironment during experimental Plasmodium berghei infection: consequences on thymocyte development. Immunology 2010, 129:248-256.
10. + thymocytes in experimentally infected mice. Immunobiology 2011, 216:1148-1154.
11. Savino W., Ayres Martins S., Neves-dos-Santos S., et al. Thymocyte migration: an affair of multiple cellular interactions?. Braz. J. Med. Biol. Res. 2003, 36:1015-1025.
12. Curran S., Murray G.I. Matrix metalloproteinases: molecular aspects of their roles in tumor invasion and metastasis. Eur. J. Cancer 2000, 36:1621-1630.
13. P. Ócharoenrat, P.H. Rhys-Evans, D.J. Archer, S.A. Eccles, C-erb B receptors in squamous cell carcinomas of the head and neck: clinical significance and correlation with matrix metalloproteinases and vascular endothelial growth factors, Oral Oncol. 38 (2003) 73-80.
14. Souza A.P., Line S.R.P. The biology of matrix metalloproteinases. Rev. FOB 2002, 10:1-6.
15. Palossari H., Pennington C.J., Larmas M., et al. Expression profile os matrix metalloproteinases MMPs and tissue inhibitors of MMPs in mature human odontoblasts and pulp tissue. Eur. J. Oral Sci. 2003, 111:117-127.
16. Ala-Aho R., Kähari V.M. Collagenases in cancer. Biochemie 2005, 87:273-286.
17. Vicente J.C., Fresno M.F., Villalain L., Vega J.A., Hernández V.G. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma. Oral Oncol. 2005, 41:283-293.
18. Polette M., Nawrocki-Raby B., Gilles C., Clavell C., Birembaut P. Tumor invasion and matrix metalloproteinases. Crit. Rev. Oncol Hematol. 2004, 49:179-186.
19. Aoudjit F., Masure S., Opdenakker G., Potworowski E.F., St-Pierre Y. Gelatinase B (MMP-9), but not its inhibitor (TIMP-1), dictates the growth rate of experimental thymic lymphoma. Int. J. Cancer 1999, 82:743-747.
20. Savino W., Mendes-Da-Cruz D.A., Smaniotto S., Silva-Monteiro E., Villa-Verde D.M.J. Molecular mechanisms governing thymocyte migration: combined role of chemokines and extracellular matrix. Leukocyte Biol. 2004, 75:951-961.
21. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 22DDCT method. Methods 2001, 25:402-408.
22. Bradford M.M. A dye binding assay for protein. Anal. Biochem. 1976, 72:248-254.
23. J. Gameiro, P. Nagib, L. Verinaud, The thymus microenvironment in regulating thymocyte differentiation, Cell Adh. Migr. (2010) 382-390.
24. Bauer A.T., Bürgers H.F., Rabie T., Marti H.H. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J. Cereb. Blood Flow Metab. 2010, 30:837-848.
25. Bellini T., Trentini A., Manfrinato M.C. Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms. J. Biochem. 2012, 151:493-499.
26. Ramos-DeSimone N., Hahn-Dantona E., Sipley J., et al. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J. Biol. Chem. 1999, 274:13066-13076.
27. Westermarck J., Kähäri V. Regulation of matrix metalloproteinase expression in tumor invasion. FABESP J. 1999, 13:781-792.
28. M. Kivelä-Rajamäki, P. Maisi, R. Srinivas, et al., Levels and molecular forms of MMP-7 (Matrilysin-1) and MMP-8 (colagenase-2) in disease human peri-implantar sulcular fluid, J. Periodont. Res., 38 (2003) 583-590.
29. Pereira A.L.A., Veras S.S.L., Silveira E.J.D., et al. The role of matrix extracellular proteins and metalloproteinases in head and neck carcinomas: an updated review. Rev. Bras. Otorrinolaringol. 2005, 71:81-86.
30. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases structure, function, and biochemistry. Circ. Res. 2003, 92:827-839.
31. Kang T., Nagase H., Pei D. Activation of membrane-type matrix metalloproteinase 3 zymogen by the proprotein convertase furin in the trans-golgi network. Cancer Res. 2002, 62:675.
32. Odaka C., Tanioka M., Itoh T. Matrix metalloproteinase-9 in macrophages induces thymic neovascularization following thymocyte apoptosis. J. Immunol. 2004, 174:846-853.
33. Mieczkowska J., Mosiewicz J., Braud W., Kwasniewski W. Changes in the activity of connective tissue matrix enzymes in the metabolic syndrome. Arch. Med. Sci. 2010, 7:634-641.
34. Page-McCaw A., Ewald A.J., Werb Z. Matrix metalloproteinases and the regulation of tissue remodeling. Nat. Rev. Mol. Cell Biol. 2007, 8:221-233.
35. Corbel M., Boichot E., Lagente V. Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury. Braz. J. Med. Biol. Res. 2000, 33:749-754.
36. Yu Q., Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev. 2000, 14:163-176.
37. Sengupta N., Macdonald T.T. The role of matrix metalloproteinases in stromal/epithelial interactions in the gut. Physiol. 2007, 22:401-409.